Dr Roberto Salgado
Honorary Clinical Senior Fellow
The Sir Peter MacCallum Department of Oncology
566 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Clarifying validation terminologies in healthcare
DOI: 10.1038/s41746-026-02471-22026
Journal article
AI-powered and manual assessment of tumor-infiltrating lymphocytes in early HER2-positive breast cancer in NSABP B-41
DOI: 10.1038/s41523-026-00961-w2026
Journal article
Leveraging artificial intelligence to strengthen cancer care in Belgium: a policy brief from the Belgian Europe’s Beating Cancer Plan Mirror Group
DOI: 10.1016/j.esmorw.2026.1007802026
Journal article
Stage-related transcriptional changes in HR-positive/HER2-negative breast cancer
DOI: 10.1038/s41523-026-00973-62026
Journal article
AI-assisted image analysis of tumor-infiltrating lymphocytes as a prognostic marker in chemotherapy-naïve luminal breast cancer
DOI: 10.1038/s41523-026-00999-w2025
Research grants (international)
Validation and Comparison of Computational Pathology-Measured Immune-Biomarkers Using AI-and AI-foundation Models With Patient Level Outcomes in Multiple Randomized Breast Cancer Trials.
2014
Journal article
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data
DOI: 10.1186/s13059-014-0470-7
RECENT SCHOLARLY WORKS
2026
Journal article
Analysis of computational tumor-infiltrating lymphocytes in breast cancer from the results of the TIGER challenge
DOI: 10.1038/s41467-026-72956-x2026
Journal article
Eosinophils in Breast Cancer: One for All and All for One.
DOI: 10.1200/JCO-26-022582026
Journal article
The immunology of human breast cancer
DOI: 10.1038/s41577-026-01307-02026
Journal article
Unified definition of integrated diagnostics: a position statement of the EFLM
DOI: 10.1515/cclm-2026-09492026
Journal article
Spatial structures of tumor and immune cells shape outcomes in ER⁺HER2⁻ and triple-negative breast cancer
DOI: 10.1038/s41523-026-01028-6